ATE307802T1 - Verfahren zur kristallisierung eines tetrahydropyridinderivates und die so erhaltenen kristallinen formen - Google Patents

Verfahren zur kristallisierung eines tetrahydropyridinderivates und die so erhaltenen kristallinen formen

Info

Publication number
ATE307802T1
ATE307802T1 AT97952986T AT97952986T ATE307802T1 AT E307802 T1 ATE307802 T1 AT E307802T1 AT 97952986 T AT97952986 T AT 97952986T AT 97952986 T AT97952986 T AT 97952986T AT E307802 T1 ATE307802 T1 AT E307802T1
Authority
AT
Austria
Prior art keywords
crystalizing
crystalline forms
tetrahydropyridine derivative
tetrahydropyridine
derivative
Prior art date
Application number
AT97952986T
Other languages
English (en)
Inventor
Antoine Caron
Bruno Franc
Olivier Monnier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE307802T1 publication Critical patent/ATE307802T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97952986T 1996-12-23 1997-12-23 Verfahren zur kristallisierung eines tetrahydropyridinderivates und die so erhaltenen kristallinen formen ATE307802T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615904A FR2757543B1 (fr) 1996-12-23 1996-12-23 Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
PCT/FR1997/002393 WO1998028271A1 (fr) 1996-12-23 1997-12-23 Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Publications (1)

Publication Number Publication Date
ATE307802T1 true ATE307802T1 (de) 2005-11-15

Family

ID=9499043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952986T ATE307802T1 (de) 1996-12-23 1997-12-23 Verfahren zur kristallisierung eines tetrahydropyridinderivates und die so erhaltenen kristallinen formen

Country Status (39)

Country Link
EP (1) EP0950050B1 (de)
JP (2) JP4499188B2 (de)
KR (1) KR100586670B1 (de)
CN (1) CN1129580C (de)
AR (1) AR009672A1 (de)
AT (1) ATE307802T1 (de)
AU (1) AU736697B2 (de)
BR (1) BR9714081A (de)
CA (1) CA2275596C (de)
CO (1) CO5070688A1 (de)
CZ (1) CZ296689B6 (de)
DE (1) DE69734460T2 (de)
DK (1) DK0950050T3 (de)
DZ (1) DZ2383A1 (de)
EE (1) EE04188B1 (de)
EG (1) EG21567A (de)
ES (1) ES2251038T3 (de)
FR (1) FR2757543B1 (de)
HK (1) HK1024002A1 (de)
HR (1) HRP970699B1 (de)
HU (1) HU227425B1 (de)
IL (1) IL129938A (de)
IN (1) IN186976B (de)
IS (1) IS2357B (de)
MY (1) MY118015A (de)
NO (1) NO312364B1 (de)
NZ (1) NZ336130A (de)
PL (1) PL190494B1 (de)
RS (1) RS49882B (de)
RU (1) RU2192416C2 (de)
SA (1) SA98180971B1 (de)
SI (1) SI0950050T1 (de)
SK (1) SK285088B6 (de)
TR (1) TR199901363T2 (de)
TW (1) TW518322B (de)
UA (1) UA60324C2 (de)
UY (1) UY24825A1 (de)
WO (1) WO1998028271A1 (de)
ZA (1) ZA9711576B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2782082B3 (fr) * 1998-08-05 2000-09-22 Sanofi Sa Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
WO2011111857A1 (ja) 2010-03-12 2011-09-15 株式会社日本触媒 吸水性樹脂の製造方法
ES2604405T3 (es) * 2011-04-15 2017-03-06 Emcure Pharmaceuticals Limited Un procedimiento para rilpivirina mejorado

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
HK1024002A1 (en) 2000-09-29
PL190494B1 (pl) 2005-12-30
SI0950050T1 (sl) 2006-04-30
KR20000069504A (ko) 2000-11-25
HUP0001387A2 (hu) 2000-09-28
MY118015A (en) 2004-08-30
NO993076D0 (no) 1999-06-22
RS49882B (sr) 2008-08-07
DE69734460T2 (de) 2006-07-06
ES2251038T3 (es) 2006-04-16
EP0950050A1 (de) 1999-10-20
FR2757543B1 (fr) 1999-04-02
KR100586670B1 (ko) 2006-06-07
TR199901363T2 (xx) 1999-08-23
HRP970699B1 (en) 2007-03-31
FR2757543A1 (fr) 1998-06-26
PL334256A1 (en) 2000-02-14
UY24825A1 (es) 1998-04-21
IS5076A (is) 1999-06-10
IN186976B (de) 2001-12-22
DZ2383A1 (fr) 2002-12-28
SK285088B6 (sk) 2006-06-01
CN1241180A (zh) 2000-01-12
HU227425B1 (en) 2011-05-30
HUP0001387A3 (en) 2002-03-28
HRP970699A2 (en) 1998-10-31
EP0950050B1 (de) 2005-10-26
NO993076L (no) 1999-06-22
DK0950050T3 (da) 2006-01-23
BR9714081A (pt) 2000-05-09
CZ296689B6 (cs) 2006-05-17
JP2001507012A (ja) 2001-05-29
CO5070688A1 (es) 2001-08-28
IS2357B (is) 2008-04-15
ZA9711576B (en) 1998-06-25
SK82899A3 (en) 1999-12-10
UA60324C2 (uk) 2003-10-15
TW518322B (en) 2003-01-21
CZ229299A3 (cs) 1999-09-15
JP4499188B2 (ja) 2010-07-07
AU736697B2 (en) 2001-08-02
CN1129580C (zh) 2003-12-03
WO1998028271A1 (fr) 1998-07-02
JP2009197022A (ja) 2009-09-03
RU2192416C2 (ru) 2002-11-10
CA2275596A1 (en) 1998-07-02
YU28999A (sh) 2003-01-31
EE9900264A (et) 2000-02-15
NO312364B1 (no) 2002-04-29
EG21567A (en) 2001-12-31
DE69734460D1 (de) 2005-12-01
CA2275596C (en) 2005-10-11
EE04188B1 (et) 2003-12-15
AR009672A1 (es) 2000-04-26
IL129938A (en) 2004-06-20
SA98180971B1 (ar) 2006-09-13
AU5668498A (en) 1998-07-17
IL129938A0 (en) 2000-02-29
NZ336130A (en) 2001-01-26

Similar Documents

Publication Publication Date Title
DE59702885D1 (de) Vorrichtung und verfahren zum herstellen eines dreidimensionalen objektes
DE59501852D1 (de) Verfahren und vorrichtung zum herstellen dreidimensionaler objekte
DE59408364D1 (de) Verfahren und vorrichtung zum herstellen eines dreidimensionalen objekts
DE59504444D1 (de) Verfahren und vorrichtung zum herstellen eines dreidimensionalen objektes
DE59901586D1 (de) Vorrichtung und Verfahren zum Herstellen eines dreidimensionalen Objektes
ATE194524T1 (de) Verfahren und vorrichtung zum herstellen einer dosendeckelrille
DE69631646D1 (de) Gegossener Flächenhaftverschluss sowie Verfahren und Vorrichtung zu dessen Herstellung
DE69718870D1 (de) Vorrichtung und Verfahren zum Schmelzblasen
DE69731116D1 (de) Verfahren und vorrichtung zur energiegewinnung
DE69735729D1 (de) Verfahren und Vorrichtung zum formen von Düsen
DE69727275D1 (de) Verfahren und Vorrichtung zum Herstellen einer Kunststofflinse
DE59305645D1 (de) Verfahren und vorrichtung zum herstellen eines dreidimensionalen objekts
DE69534366D1 (de) Verfahren und vorrichtung mit mehreren gravierköpfen
DE69211855T2 (de) Verfahren und vorrichtung zum anpassen der kreppbedingungen
DE69515447T2 (de) Verfahren und Vorrichtung zur Herstellung eines Flächenhaftverschluss
DE59804018D1 (de) Drückwalzvorrichtung und Verfahren zur Herstellung eines planverzahnten Werkstückes
DE59506572D1 (de) Vorrichtung und Verfahren zum Herstellen von Rohren
DE59913596D1 (de) Verfahren und vorrichtung zum herstellen eines hochorientierten fadens
DE59503553D1 (de) Vorrichtung und verfahren zum herstellen einer spulenanordnung
DE69730291D1 (de) Verfahren zum herstellen einer justiermarke in einer harzschablone und so hergestellte schablone
DE69715813D1 (de) Verfahren und vorrichtung zum herstellen durch formen
DE59801920D1 (de) Verfahren und vorrichtung zum Herstellen eines (Zigaretten-) Strangs
DE59500643D1 (de) Verfahren und vorrichtung zum herstellen eines dreidimensionalen objektes
DE69332271T2 (de) Verfahren und vorrichtung zum strangpressen
DE69707687T2 (de) Verfahren und vorrichtung zum genauen herstellen eines depolarisierers

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0950050

Country of ref document: EP